Appeal No. 1996-2209
Application No. 08/031,346
Claims 1, 25 and 26 are illustrative of the claims on appeal and read as follow:
1. A process for the production of germicidally treated suspensions comprising
taking body fluids from a person suffering from a member of the group of illnesses
consisting of atopic neurodermatitis, bronchial asthma and nasal allergies, colitis ulcerosa,
Parkinson, Morbus Crohn, Hepatitis, chronic Hepatitis, chronic Sinusitis, Psoriasis, rheumatic-
type indications, carcinomas, multiple sclerosis, and scleroderma Sjögren syndrome and
combinations thereof;
desaggregating the body fluids by reducing the body fluids to sub-cell size substances
by cell lysis;
subjecting a member selected of the group consisting of body fluids, sub-cell size
substances, and mixtures thereof to an oxidant by exposing the member selected of the group
consisting of body fluids, sub-cell size substances to a member selected from the group
consisting of ozone, oxygen, UV radiation, and mixtures thereof for obtaining suspensions
exhibiting immune-modulatory active properties.
25. A process for the production of germicidally treated suspensions comprising
taking body fluids formed of tissue from a person suffering from a member of the group
of illnesses consisting of atopic neurodermatitis, bronchial asthma and nasal allergies,
allergies, colitis ulcerosa, Parkinson, Morbus Crohn, Hepatitis, chronic Hepatitis, chronic
Sinusitis, Psoriasis, rheumatic-type indications, carcinomas, multiple sclerosis, and
scleroderma Sjögren syndrome and combinations thereof;
fractionating the tissue by reducing the tissue to sub-cell size substances by cell lysis
for obtaining a first fraction and a second fraction;
subjecting the first fraction to an oxidant with a member selected from the group
consisting of ozone, oxygen, UV radiation and mixtures thereof;
subjecting a member selected from the group consisting of the second fraction, a
separately generated fractionated sub-cell size substance, tissue, and mixtures thereof to an
2
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next
Last modified: November 3, 2007